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Euglena gracilis, a unicellular phytoflagellate microalga, is a promising biomate-
rial for foods, feeds, and biofuels. However, targeted mutagenesis in this species
has been a long-standing challenge. We recently developed a transgene-free,
highly efficient, genome editingmethod for E. gracilis using CRISPR/Cas9 ribonu-
cleoproteins (RNPs). Our method achieved mutagenesis rates of approximately
80% or more through an electroporation-based direct delivery of Cas9 RNPs.
Therefore, this method is suitable for basic research and industrial applications,
such as the breeding of Euglena.
For complete details on the use and execution of this protocol, please refer to
Nomura et al. (2019).BEFORE YOU BEGIN
CRITICAL: All procedures in this protocol are performed aseptically on a clean bench.Culture of Euglena gracilis
TIMING: 3–7 days
1. Euglena gracilis Z strain was cultured using KHmedium (Koren, 1967) adjusted to pH 5.5 with po-
tassium hydroxide on a rotary shaker (120 rpm) at 28C under continuous light (50 mmol photons
m2 s1) conditions.
2. The culture was maintained by inoculating 100 mL into 50mL of fresh KHmedium every week (Fig-
ures 1A and 1C).
3. For the direct delivery of Cas9 ribonucleoproteins (RNPs) by electroporation, E. gracilis cells that
have been cultured for 3 days are used (Figure 1B).STAR Protocols 1, 100023, June 19, 2020 ª 2020 The Author(s).
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. Liquid Culture of Euglena gracilis
Just after the E. gracilis cells were transferred to fresh KH medium (A), after culturing for 3 days (B), and 7 days (C).
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OPEN ACCESS ProtocolKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Chemicals, Peptides, and Recombinant Proteins
Alt-R CRISPR-Cas9 tracrRNA Integrated DNA Technologies 1072532
Alt-R CRISPR-Cas9 crRNA Integrated DNA Technologies N/A
Alt-R S.p. Cas9 Nuclease V3 Integrated DNA Technologies 1081058
Ultramer DNA Oligos Integrated DNA Technologies N/A
Kaneka Easy DNA Extraction Kit v.2 Kaneka KN-T110005
Tks Gflex DNA Polymerase Takara Bio R060A
CloneJET PCR Cloning Kit Thermo Scientific K1231
Alt-R Genome Editing Detection Kit Integrated DNA Technologies 1075931
(NH4)2HPO4 FUJIFILM Wako Pure Chemical Corporation 016-03325
KH2PO4 FUJIFILM Wako Pure Chemical Corporation 169-04245
MgSO4・7H2O FUJIFILM Wako Pure Chemical Corporation 131-00405
CaCl2 FUJIFILM Wako Pure Chemical Corporation 038-24985
Fe2 (SO4)3・nH2O FUJIFILM Wako Pure Chemical Corporation 091-02832
MnCl2・4H2O FUJIFILM Wako Pure Chemical Corporation 139-00722
ZnSO4・7H2O FUJIFILM Wako Pure Chemical Corporation 264-00402
CoSO4・7H2O FUJIFILM Wako Pure Chemical Corporation 032-03802
Na2MoO4・2H2O FUJIFILM Wako Pure Chemical Corporation 196-02472
CuSO4・5H2O FUJIFILM Wako Pure Chemical Corporation 039-04412
Vitamin B1 (Thiamin) FUJIFILM Wako Pure Chemical Corporation 201-00852
Vitamin B12 FUJIFILM Wako Pure Chemical Corporation 226-00343
10% Sulfuric acid FUJIFILM Wako Pure Chemical Corporation 198-11705
Potassium hydroxide FUJIFILM Wako Pure Chemical Corporation 168-21815
Experimental Models: Organisms/Strains
Euglena gracilis Z Institute of Applied Microbiology
(IAM) culture collection
IAM E-6, NIES-48
(Continued on next page)
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Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Other
BioTRON NK systems LPH-411SP
Shake-LR TAITEC 0054809-000
T100 Thermal Cycler Bio-Rad #1861096
NEPA21 Super Electroporator Nepa Gene N/A
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OPEN ACCESSProtocolMATERIALS AND EQUIPMENT
Design of the Target Sequence for crRNA Synthesis
Normally, the target sequence used is 20 bp upstream of the protospacer adjacent motif sequence (5’-
NGG-3’). TheGCcontent of the target sequence shouldbe40%–60%. It is recommended todesign two
or more target sequences for one target gene.
Preparation of Stock crRNA and tracrRNA Solutions (100 mM) with Nuclease-free Duplex
Buffer
Alt-R CRISPR-Cas9 crRNA (CRISPR RNA) and tracrRNA (trans-activating crRNA) were synthesized by
Integrated DNA Technologies (IDT), and a 100-mM solution was prepared using nuclease-free
duplex buffer (IDT).
Note: The stock solution can be stored at 20C.
Preparation of the Modified CM Medium (Cramer and Myers, 1952)
 Prepare a modified CM medium with the following composition.Composition of Modified CM Medium
Reagent Weight per L
(NH4)2HPO4 1.0 g
KH2PO4 1.0 g
MgSO4・7H2O 0.2 g
CaCl2 0.02 g
Fe2 (SO4)3・nH2O 3 mg
MnCl2・4H2O 1.8 mg
ZnSO4・7H2O 0.4 mg
CoSO4・7H2O 1.5 mg
Na2MoO4・2H2O 0.2 mg
CuSO4・5H2O 0.02 mg
Vitamin B1 0.1 mg
Vitamin B12 0.0005 mg
Adjust the pH to 5.5 with 10% sulfuric acid.
Autoclave at 121C for 15 min.Note: CM medium can be stored at 20C–25C.Preparation of Electroporation Solution
 Prepare a 0.3-M sucrose solution and sterilize using a 0.2-mm pore size syringe filter.
 Mix the modified CM medium and the filter sterilized sucrose solution at a ratio of 3:2 (v/v).STAR Protocols 1, 100023, June 19, 2020 3
Table 1. Alt-R CRISPR-Cas9 crRNA Reagent Volumes Used in Each Electroporation Reaction
Reagent (mM) Volume (mL)
Alt-R CRISPR-Cas9 crRNA (100) 0.6
Alt-R CRISPR-Cas9 tracrRNA (100) 0.6
Total volume 1.2
Tab
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ProtocolNote: The electroporation solution can be stored at 20C–25C.
Alternatives: This protocol can be implemented using other thermal cyclers, plant growth
chambers, and orbital shakers with equivalent device performance as the above equipment.STEP-BY-STEP METHOD DETAILS
Preparation of Cas9 RNPs
TIMING: 30 min
This step describes the procedure to prepare Cas9 RNP complexes for electroporation.
1. Equal amounts of crRNA and tracrRNA solution (100 mM stock) were mixed in a 0.2-mL PCR tube.
An example of the reagent amounts used for one electroporation reaction is shown in Table 1.
2. The mixture was heated at 95C for 5 min and then cooled to 20C using a thermal cycler with a
ramp rate setting of 0.1C/s.
Alternatives: Heated crRNA-tracrRNA complex can be cooled on the bench at 20C–25C.
3. Alt-R S.p. Cas9 Nuclease V3 (IDT, 62 mM solution) was added to the cooled gRNA complex. Ex-
amples of the amount of reagent used for one electroporation reaction are shown in Table 2.
4. To form the Cas9 RNP complexes, the mixture was incubated for 15 min at 20C–25C.
PAUSE POINT: The Cas9 RNP complex can be stored at 80C for 6 months.Direct Delivery of Cas9 RNPs by Electroporation
TIMING: 10–20 min
This step describes the procedure to deliver Cas9 RNPs to E. gracilis cells by electroporation.
5. E. gracilis was cultured in KH medium (pH 5.5) for 3 days (Figure 1B), and 1 mL of the cell culture
was transferred to a 1.5 mL tube (Figure 2A).
Note: The optical density at 600 nm of 10-fold dilution of E. gracilis after 3 days of culture is
approximately 0.5–0.7.
6. The cell culture sample was centrifuged at 4003 g for 30 s (Figure 2B), and the supernatant was
removed.le 2. crRNA-tracrRNA Complex and Alt-R CRISPR-Cas9 crRNA Reagent Volumes Used in Each Electroporation
agent (mM) Volume (mL)
NA-tracrRNA complex 1.2
t-R S.p. Cas9 Nuclease V3 (62) 0.8
tal volume 2.0
STAR Protocols 1, 100023, June 19, 2020
Figure 2. Preparation of the Suspension of E. gracilis Cells for Electroporation
Transfer of cultured E. gracilis cells (A), E. gracilis cells pellet after centrifugation (B), Resuspended E. gracilis cells (C).
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OPEN ACCESSProtocol7. The cells were then resuspended with the addition of 1 mL of electroporation solution.
8. The cell suspension was centrifuged at 400 3 g for 30 s, and the supernatant was removed.
9. The cells were resuspended in electroporation solution at a concentration of 1 3 106 cells/mL
(Figure 2C).
10. Then, 48 mL of the E. gracilis suspension was transferred to 0.2 mL new tube (Figure 3A).
11. Finally, 2 mL of Cas9 RNP complex solution was added and the solution was mixed several times
by pipetting (Figure 3B). Alternatively, to prevent the loss of Cas9 RNPs solution, the E. gracilis
suspension can be directly transferred to a tube containing 2 mL of the RNP complex solution.
CRITICAL: The amount of Cas9 RNPs is important. If the RNP amount is reduced, the
genome editing efficiency will decrease.
12. The Cas9 RNPs and E. gracilis suspension mixture was transferred to a 2-mm gap cuvette (EC-
002; Nepa Gene) (Figure 3C).
13. The cuvette was tapped to drop the Cas9 RNP and cell suspension mixture to the bottom of the
cuvette (Figure 3D).
14. A NEPA21 Super Electroporator (Nepa Gene) was used for the introduction of the RNP com-
plexes. The electroporation conditions are shown in Table 3 and Figure 4A.
15. The cuvette was inserted into the electrode chamber (Figure 4B), and the ‘‘U’’ switch was
pressed. The impedance value was usually approximately 0.4–0.5 kU (Figure 4C).Figure 3. Preparation Procedure for Cas9 RNPs Introduction by Electroporation
Transfer of resuspended E. gracilis cells (A), Addition of Cas9 RNPs (B), Transfer of Cas9 RNPs and cell suspension mixture to cuvette (C), Tapping of the
cuvette (D).
STAR Protocols 1, 100023, June 19, 2020 5
Table 3. Settings for the NEPA21 Super Electroporator
Poring Pulse Transfer Pulse
Voltage (V) 300 20
Pulse length (ms) 5 50
Pulse interval (ms) 50 50
Number of pulses 2 5
Decay rate (%) 40 40
Polarity switching + G
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OPEN ACCESS Protocol16. The ‘‘Start’’ switch was pressed to initiate electroporation (Figure 4D).
17. After electroporation, 1 mL of KH medium (pH 5.5) was added to the cuvette (Figures 5A and
5B).
18. The cell suspension was transferred to a 12-well plate (Figure 5C) and cultured on a rotary shaker
(120 rpm) at 28C under dark conditions (by covering with aluminum foil) for 24–72 h (Figures 5D
and 5E).
Note: Seal the plate with parafilm and surgical tape to prevent evaporation of the culture
medium.Single-Stranded Oligodeoxynucleotide-Mediated Knockin (Optional)
TIMING: 5 min
The high-efficiency knockin of short sequences (50 bp) is possible by introducing the Cas9 RNPs
and single-stranded oligodeoxynucleotides (ssODNs) with 50 bp upstream and downstream homol-
ogy sequence arms of the target site (Nomura et al., 2019).
19. ssODNs were synthesized by IDT, and a 200 mM solution was prepared with nuclease-free
duplex buffer (IDT)
20. For electroporation, 2 mL of RNP complex solution and 1 mL of 200 mM ssODN stock solution
were added to 47 mL of the E. gracilis suspension.
Note: It is possible to rewrite the target base using an ssODN containing the nucleotide sub-
stitutions. In this case, to prevent re-cleavage by Cas9 RNPs, two ormore basemismatches are
required in the seed region of the target sequence in ssODN.Figure 4. Operation Procedure for the Electroporator
Settings of the electroporator (A), Insertion of the cuvette into the electrode chamber (B), Measurement of the impedance value (C), Initiation of
electroporation (D).
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Figure 5. Procedure of Recovery Culture after Electroporation
Ejection of the cuvette from the electrode chamber (A), Addition of KHmedium (B), Transfer of cell suspension to well plate (C), Covering of culture plate
with aluminum foil (D) and recovery culture on a rotary shaker (E).
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TIMING: 3 h or more
For the detection of mutagenesis at on-target sites in Cas9 RNP-introduced E. gracilis, a T7 endo-
nuclease I (T7EI) mismatch cleavage assay was performed using an Alt-R Genome Editing Detection
Kit (IDT).
21. The DNA template was extracted from the small E. gracilis cells pellet (Figure 6A) using a Kaneka
Easy DNA Extraction Kit v.2 (Kaneka).
Note: Alternatively, another DNA extraction kit can be used.
22. DNA fragments, including the target sites, were amplified by Tks Gflex DNA Polymerase (Takara
Bio) using the specific primer set.
23. Using the amplified DNA fragments, the T7EI treatment was performed according to the prod-
uct manufacturer’s instructions.
24. The digested DNA fragments weremonitored using 1% agarose gel electrophoresis (Figure 6B).
Note: Because T7EI does not recognize single-base indels, the T7EI assay estimates a lower
editing efficiency rate.Pure-Line (Single-Cell-Derived Clone) Isolation from a Single E. gracilis Cell
TIMING: 1 week or more
This step describes how to obtain a single-cell-derived clone in E. gracilis.Figure 6. Example of T7 Endonuclease I Mismatch Cleavage Assay
Small E. gracilis cells pellet after recovery culture for DNA extraction (A) and example of T7E1 assay results (B).
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Figure 7. Procedure of Pure-Line Isolation from Single Cell of E. gracilis
A single E. gracilis cell isolation using a micro pick-and-place system (A and B), Culture from isolated single E. gracilis cell (C and D).
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OPEN ACCESS Protocol25. Following electroporation after 24–72 h culture in KH medium, a single cell was isolated using a
micro pick-and-place system (Nepa Gene) (Figures 7A and 7B).
Alternatives: A single cell of E. gracilis can be manually isolated using a glass capillary pipette
or cell sorter.
26. The isolated single cell was cultured forR7 days using KHmedium to obtain a pure line (Figures
7C and 7D).
Note: Contamination can be suppressed by using KH medium at pH 3.5 for culture.Genotyping by Sanger Sequencing
TIMING: 3 days
This step describes Sanger sequencing for genotyping of E. gracilis.
27. The DNA template was extracted from a 5–10-mL cell pellet volume of E. gracilis using the Ka-
neka Easy DNA Extraction Kit v.2 (Kaneka).
28. DNA fragments, including the target sites, were amplified by Tks Gflex DNA Polymerase using
the specific primer set for target site.
Note: A PCR product length of approximately 500–1000 bp is suitable for genotyping.
29. To clone the PCR products, we used a CloneJET PCR cloning kit (Thermo Fisher Scientific).
30. Colonies were then selected with the vector containing the insert DNA by colony PCR.
31. Each plasmid was extracted using a plasmid DNA extraction Mini Kit (FAVORGEN), and se-
quences were determined using Sanger sequencing.EXPECTED OUTCOMES
Euglena gracilis, a unicellular phototrophic protist, is a promising material for foods, feeds, and bio-
fuels. However, the development of a targeted mutagenesis method in this species has been a long-
standing challenge. Among the current genetic manipulation technologies, genome editing by the
direct delivery of RNPs has various advantages, including time effectiveness, a low cytotoxicity, a high
efficiency, and the reduction of off-target effects (Jeon et al., 2017). In our method, insertion and/or
deletion (Indel) mutations rate of 77.7%–90.1% has been detected by amplicon sequencing in two
different target sequences in the EgGSL2 gene (Nomura et al., 2019). Therefore, our developed
RNP-based genome editing in E. gracilis opens up new avenues to reveal the functions of genes.8 STAR Protocols 1, 100023, June 19, 2020
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OPEN ACCESSProtocolIn addition, basedonour developedmethod, it will be possible to develop convenientCRISPR-based
technology for the basic research of E. gracilis, such as chromosome visualization and epigenome ed-
iting (Doudna and Charpentier, 2014; Wang et al., 2016). Furthermore, RNP-based genome editing
without transgenes is suitable for industrial use because it can potentially bypass the regulation of
genetically modified organisms. Thus, RNP-based genome editing in E. gracilis paves the way for
improving its industrially relevant traits to promote production of bio-based material.LIMITATIONS
Because the published genome sequence information of E. gracilis strain Z1 appears to be frag-
mented (Ebenezer et al., 2019), it has been difficult to precisely assess the off-target effects of
genome editing in E. gracilis. This limitation will be resolved by improving the genome assembly
of E. gracilis. To confirm a phenotypic change by on-target in genome-edited strains, several target
sites for a target gene should be examined. Off-target effect can be suppressed by reducing the
amount of RNPs and using a truncated (18 bp) target sequence (Fu et al. 2014). Furthermore,
off-target can be reduced by the use of S.p. HiFi Cas9 Nuclease V3 (IDT).
In case a different strain of E. gracilis is used, efficiency may decrease due to differences in cell prop-
erties, such as growth rate. Therefore, in such cases, the protocol for each strain needs to be opti-
mized. In addition, there is a possibility that parts of the genomic DNA sequence vary depending
on the strain of E. gracilis used. Before designing the target sequence, it is also necessary to obtain
information on the surrounding DNA sequence of the target site by cloning and sequencing.
The maximum length of single-stranded DNAs that can be knocked in in our protocol remains undeter-
mined. It is generally considered that thehomologyarmneeds tobe lengthenedaccording to the length
of the DNA to be knocked in. Although the present method has enabled us to precisely knockin a DNA
fragment of at least 50 bp in length, an improvement in our method for the knockin of longer DNAs in
E. graciliswill provide opportunities to engineerE. gracilis cells to enhance its productivity and function.TROUBLESHOOTING
Problem
Low mutagenesis efficiencyPotential Solution
In caseswhen the genome-edited cells exhibit a slowgrowthphenotype, themutagenesis efficiency could
bedecreaseddue to the faster growthofwild-type cells. Thisproblemcanbesolvedbyearlier cell isolation
(e.g., 24 h) after the introduction of Cas9 RNPs. On the other hand, if the performance of the designed
target sequence is poor it can be improved by doubling the amount (4 mL/total 50 mL reaction) of Cas9
RNPs used for electroporation.ACKNOWLEDGMENTS
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